Status:
RECRUITING
China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization
Lead Sponsor:
China-Japan Friendship Hospital
Conditions:
Pulmonary Hypertension
Pulmonary Embolism (Diagnosis)
Eligibility:
All Genders
14+ years
Brief Summary
Right heart catheterization(RHC) plays a crucial role in the diagnosis and treatment of pulmonary vascular diseases(PVD). In China, the lack of equipment and technical expertise has historically limit...
Detailed Description
This study is led by the China-Japan Friendship Hospital and will be conducted across approximately 30 pulmonary hypertension centers in China. It is an observational cohort study without intervention...
Eligibility Criteria
Inclusion
- Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension
- Age ≥14 years old
Exclusion
- Vital data missing
- Did not sign informed consent or did not agree to follow-up
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06954727
Start Date
January 1 2018
End Date
December 31 2030
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, China